Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMultiple MyelomaRemission InductionTransplantation ConditioningPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMelphalanBone MarrowCombined Modality TherapyTreatment OutcomeBone Marrow CellsSalvage TherapyCyclophosphamideDisease-Free SurvivalRecurrenceCytarabineLymphoma, Non-HodgkinEtoposideHodgkin DiseaseStem CellsBone Marrow PurgingHematopoietic Stem Cell MobilizationGraft vs Host DiseaseCarmustineSurvival RateVincristineHematopoietic Stem CellsMyeloablative AgonistsSurvival AnalysisWhole-Body IrradiationLiver TransplantationGraft SurvivalHematologic NeoplasmsRetrospective StudiesBusulfanAntigens, CD34PrognosisThiotepaDoxorubicinFollow-Up StudiesGranulocyte Colony-Stimulating FactorLeukemia, Myeloid, AcuteTime FactorsDexamethasonePrednisoneAntibodies, Monoclonal, Murine-DerivedKidney TransplantationLymphoma, Mantle-CellLeukapheresisAntineoplastic Agents, AlkylatingAntineoplastic AgentsAmyloidosisThalidomideNeoplasm, ResidualCell TransplantationLymphomaBone and BonesTransplantation ChimeraBoronic AcidsLymphoma, FollicularPyrazinesTissue DonorsLymphoma, T-Cell, PeripheralMesenchymal Stem Cell TransplantationIfosfamideMyelodysplastic SyndromesIdarubicinImmunosuppressive AgentsAutograftsLeukemiaHematopoiesisInduction ChemotherapyCord Blood Stem Cell TransplantationLeukemia, MyeloidPodophyllotoxinLymphoma, Large B-Cell, DiffuseHeart TransplantationCell DifferentiationAntibodies, MonoclonalPrecursor Cell Lymphoblastic Leukemia-LymphomaProspective StudiesHistocompatibility TestingMaintenance ChemotherapyBlood Component RemovalLung TransplantationMitoxantroneLymphoma, B-CellFeasibility StudiesAcute DiseaseCells, CulturedNeoplasm Recurrence, LocalBone Marrow DiseasesDrug Administration ScheduleGraft RejectionFlow CytometryTransplantation Immunology